Literature DB >> 200940

Cell-free synthesis of the precursor polypeptide for avian myeloblastosis virus DNA polymerase.

B M Paterson, D J Marciani, T S Papas.   

Abstract

High molecular weight RNA (35S) isolated from avian myeloblastosis virus directs the cell-free synthesis of two prominent polypeptides of 180,000 and 76,000 molecular weight. The latter polypeptide has previously been identified as the precursor to the group-specific antigens of the virus ("gag" proteins) [Vogt, V. M., Eisenman, R. & Diggelmann, H. (1975) J. Mol. Biol. 96, 471-493]. Two-dimensional tryptic peptide analyses of the [35S]methionine-labeled peptides demonstrate that the 180,000-dalton product is a polyprotein that can account for all the peptides of the avian myeloblastosis virus DNA polymerase (DNA nucleotidyltransferase, EC 2.7.7.7) and those of the gag viral proteins. This is direct confirmation of the genomic order of the viral structural genes, placing the polymerase gene adjacent to the 5'-proximal gag gene of the virus. Furthermore, our findings suggest that the primary polymerase gene product is the beta subunit of the enzyme. These results are discussed in relation to the proposed structural gene map for the avian retraviruses and suggest a model for the in vivo processing of the viral polymerase.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 200940      PMCID: PMC432075          DOI: 10.1073/pnas.74.11.4951

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Cell-free synthesis of two proteins unique to RNA of transforming virions of Rous sarcoma virus.

Authors:  J Kamine; J M Buchanan
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

2.  Cell-free translation of virion RNA from nondefective and transformation-defective Rous sarcoma viruses.

Authors:  T Pawson; G S Martin; A E Smith
Journal:  J Virol       Date:  1976-09       Impact factor: 5.103

3.  Viral DNA-dependent DNA polymerase and the properties of thymidine labelled material in virions of an oncogenic RNA virus.

Authors:  J Ríman; G S Beaudreau
Journal:  Nature       Date:  1970-10-31       Impact factor: 49.962

4.  Changes in the mRNA population of chick myoblasts during myogenesis in vitro.

Authors:  B M Paterson; J O Bishop
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

5.  An efficient mRNA-dependent translation system from reticulocyte lysates.

Authors:  H R Pelham; R J Jackson
Journal:  Eur J Biochem       Date:  1976-08-01

6.  RNA-dependent DNA polymerase of avian sarcoma virus B77. I. Isolation and partial characterization of the alpha, beta2, and alphabeta forms of the enzyme.

Authors:  A Hizi; W K Joklik
Journal:  J Biol Chem       Date:  1977-04-10       Impact factor: 5.157

7.  Studies on the reverse transcriptase of RNA tumor viruses. Structural relatedness of two subunits of avian RNA tumor viruses.

Authors:  W Gibson; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

8.  Mechanism of release of active alpha subunit from dimeric alpha beta avian myeloblastosis virus DNA polymerase.

Authors:  T S Papas; D J Marciani; K Samuel; J G Chirikjian
Journal:  J Virol       Date:  1976-06       Impact factor: 5.103

9.  Serological analysis of the deoxyribonucleic acid polymerase of avian oncornaviruses. II. Comparison of avian deoxyribonucleic acid polymerases.

Authors:  R C Nowinski; K F Watson; A Yaniv; S Spiegelman
Journal:  J Virol       Date:  1972-11       Impact factor: 5.103

10.  The 3'-terminal nucleosides of the high molecular weight RNA of avian myeloblastosis virus.

Authors:  M L Stephenson; L S Wirthlin; J F Scott; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1972-05       Impact factor: 11.205

View more
  30 in total

1.  5-enolpyruvylshikimate 3-phosphate synthase, the target enzyme of the herbicide glyphosate, is synthesized as a precursor in a higher plant.

Authors:  H Holländer-Czytko; N Amrhein
Journal:  Plant Physiol       Date:  1987-02       Impact factor: 8.340

2.  Synthesis and localization of a development-specific protein in sclerotia of Sclerotinia sclerotiorum.

Authors:  G M Russo; J L Van Etten
Journal:  J Bacteriol       Date:  1985-08       Impact factor: 3.490

3.  5'-terminal nucleotide sequences of mammalian type C helper viruses are conserved in the genomes of replication-defective mammalian transforming viruses.

Authors:  S R Tronick; C D Cabradilla; S A Aaronson; W A Haseltine
Journal:  J Virol       Date:  1978-06       Impact factor: 5.103

4.  Purification of virus-specific RNA from chicken cells infected with avian sarcoma virus: identification of genome-length and subgenome-leghth viral RNAs.

Authors:  J T Parsons; P Lewis; P Dierks
Journal:  J Virol       Date:  1978-07       Impact factor: 5.103

5.  Nature of Rous sarcoma virus-specific RNA in transformed and revertant field vole cells.

Authors:  R A Krzyzek; A F Lau; A J Faras
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

6.  Characterization of Rous sarcoma virus src gene products synthesized in vitro.

Authors:  K Beemon; T Hunter
Journal:  J Virol       Date:  1978-11       Impact factor: 5.103

7.  Specific RNA sequences and gene products of MC29 avian acute leukemia virus.

Authors:  P Mellon; A Pawson; K Bister; G S Martin; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

8.  Correlation of RNA binding affinity of avian oncornavirus p19 proteins with the extent of processing of virus genome RNA in cells.

Authors:  J P Leis; P Scheible; R E Smith
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

9.  Avian erythroblastosis virus produces two mRNA's.

Authors:  S M Anderson; W S Hayward; B G Neel; H Hanafusa
Journal:  J Virol       Date:  1980-12       Impact factor: 5.103

10.  Synthesis and processing of polymerase proteins of wild-type and mutant avian retroviruses.

Authors:  R N Eisenman; W S Mason; M Linial
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.